Based on the observed significant associations, we then performed stratified analysis based on pathological characteristics of the breast cancer (tumor size, lymph node involvement) and expression of specific proteins in tumor tissue (PR, ER, and HER-2). This evidence concerns the gene ERBB2 and breast carcinoma.